Cambridge Healthtech Institute第6屆

Immunomodulatory Therapeutic Antibodies for Cancer

( 癌症治療的免疫調節抗體 )

次世代免疫療法的新標的、併用、抗體工程

2018年8月27日~28日

本單元以癌症免疫治療的免疫調節抗體為主題,將討論次世代免疫療法、新標的與併用療法、克服耐受性的策略等議題,將抗體開發從臨床前研究往臨床開發階段推進所採用措施的個案研究也將在此發表。

Coverage will include, but is not limited to:

  • Emerging targets and pathways for immunomodulatory antibodies
  • Strategies to improve therapeutic efficacy and safety of novel biologics
  • Novel immunotherapies and combinations
  • Therapeutic strategies for non-responders and mechanism of resistance
  • Antibody engineering for immunotherapy
  • Case studies in clinical immuno-oncology programs

* 活動內容有可能不事先告知作更動及調整。

Choose your language
Chinese
Japanese
Korean
English





免費電子郵件通知服務